Home

MATTHEW S LEVATICH

CIK 1385208 · President & CEO · last filed 2026-02-12

MATTHEW S LEVATICH is a President & CEO who has filed 58 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider sold $239.3K of EMR on Feb 12, 2026. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.16M

Companies

2

Total Filings

58

Lifetime Open-Market Net

-$6.87M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EMR Director 24,349 $158.26 $3.85M -$676.9K 18 2026-02-12
HOG President & CEO 165,682 $26.01 $4.31M -$6.19M 37 2020-02-10

Recent Filings

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-12 EMR Sell (S) −1,476 -$239.3K EDGAR
2026-02-10 EMR Notice (144) −1,476 -$223.8K EDGAR
2026-02-05 EMR Grant (A) +1,251 $0 EDGAR
2025-02-13 EMR Sell (S) −1,867 -$233.5K EDGAR
2025-02-12 EMR Notice (144) −1,867 -$238.4K EDGAR
2025-02-06 EMR Grant (A) +1,476 $0 EDGAR
2024-02-16 EMR Sell (S) −1,933 -$204.1K EDGAR
2024-02-15 EMR Notice (144) −1,933 -$197.2K EDGAR
2024-02-08 EMR Grant (A) +1,867 $0 EDGAR
2023-02-09 EMR Grant (A) +1,933 $0 EDGAR
Showing 1–10 of 58
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.